Skip to Content Facebook Feature Image

Abortion pills will be controlled substances in Louisiana soon. Doctors have concerns

News

Abortion pills will be controlled substances in Louisiana soon. Doctors have concerns
News

News

Abortion pills will be controlled substances in Louisiana soon. Doctors have concerns

2024-09-30 22:27 Last Updated At:22:31

BATON ROUGE, La. (AP) — On Tuesday, Louisiana will become the first state in the U.S. to categorize two widely used abortion pills as “controlled dangerous substances.”

Opponents argue the classification could have catastrophic impacts in a state that already has a near-total abortion ban and one of the highest maternal mortality rates in the nation. Doctors fear the reclassification will cause delays in accessing the drugs — mifepristone and misoprostol — which together can be used to manage miscarriages, while misoprostol induces labor and treats severe bleeding after delivery. They also worry the practice of reclassifying the drugs might spread beyond Louisiana.

Proponents say the new law should help prevent coerced abortion, pointing to a Texas case in which a pregnant woman was given seven misoprostol pills by her husband without her knowledge; the baby survived. Over the past 15 years, news outlets have reported on similar cases — none in Louisiana — but the issue does not appear widespread.

Here's what you should know about the new law.

Mifepristone and misoprostol can both be obtained through a prescription in Louisiana, but the state has reclassified the pills as “Schedule IV drugs,” putting them in the same category as the opioid tramadol and other substances that can be addictive.

Mifepristone is typically taken along with misoprostol and was approved by the U.S. Food and Drug Administration in 2000 after federal regulators deemed it safe and effective for ending pregnancies in the early weeks of gestation. The drug, which blocks the hormone progesterone, also primes the uterus to respond to the contraction-causing effect of misoprostol.

Last year in the U.S., nearly two-thirds of all abortions were medication abortions.

OB-GYNs say a tiny fraction of patients suffer “major” or “serious” adverse events after taking mifepristone. In June, the Supreme Court unanimously preserved access to the drug, throwing out a lawsuit from abortion opponents that argued the FDA overlooked serious safety problems when it made mifepristone easier to obtain.

Medical experts say it's possible and safe to use misoprostol by itself to end a pregnancy, but it's slightly less effective than the two-drug regimen. Besides being used in reproductive care, misoprostol is also used to prevent stomach ulcers in people who take certain pain medicines.

It depends.

Under current Louisiana law, physicians convicted of performing an illegal abortion, including one with pills, face up to 15 years in prison, $200,000 in fines and the loss of their medical license.

The new classification means that if someone knowingly possesses mifepristone or misoprostol without a valid prescription for any purpose, they could be fined up to $5,000 and sent to jail for one to five years.

The law carves out protections for pregnant women who obtain the drug without a prescription to take on their own.

Louisiana Attorney General Liz Murrill, a Republican who supports the current abortion ban and reclassification, said in September that the “intentional delivery of these drugs by organizations operating though the internet or other networks” is illegal and they will be prosecuted.

Doctors say the law could harm patients due to extra steps and more stringent storage requirements —especially in emergencies in which misoprostol is used to manage dangerous postpartum hemorrhages.

“As soon as the clock strikes midnight ... this will be a reality almost immediately because we call for it in an emergency situation so frequently,” said Dr. Jane Martin, an OB-GYN at Ochsner Health in New Orleans whose hospital sees up to 5,000 births a year. It's “administered at least once a day on labor and delivery,” often more frequently.

In hospitals like hers, misoprostol is usually stored in an OB-GYN unit in a “hemorrhage box” in the room, on the delivery table or in a nurse’s pocket, said Martin, who is active in the American College of Obstetricians and Gynecologists in Louisiana and stressed that she's speaking for herself and not the hospital. With the new law, there will be more “red tape” to access the drugs — maybe down the hall in a locked container or potentially an in-house pharmacy at smaller hospitals.

Health experts said two alternative medications for hemorrhage have more side effects, can’t be used in patients with certain medical problems and need to be refrigerated.

Murrill countered that the law “does not limit a health care provider’s ability to use, prescribe, or fill these medications for legitimate health purposes nor does it impose restrictive burdens on access for emergency purposes.”

Dr. Kylie Cooper, a maternal-fetal specialist in Minnesota who is active with the American College of Obstetricians and Gynecologists, said that she's concerned other states will adopt restrictions like Louisiana.

Up to 5% of obstetric patients will experience postpartum hemorrhages, which cause 11% of maternal deaths in the U.S., according to The Joint Commission, a nonprofit organization that sets standards and accredits health care organizations.

“Patients can lose a large amount of blood in a very, very short timeframe," Cooper said. “So in many situations, seconds and minutes count.”

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

FILE - Bottles of abortion pills mifepristone, left, and misoprostol, right, are displayed at a clinic in Des Moines, Iowa, Sept. 22, 2010. (AP Photo/Charlie Neibergall, File)

FILE - Bottles of abortion pills mifepristone, left, and misoprostol, right, are displayed at a clinic in Des Moines, Iowa, Sept. 22, 2010. (AP Photo/Charlie Neibergall, File)

NEW YORK (AP) — U.S. stocks are hanging near their records Monday following a wild start to the week for financial markets in Asia, where Japanese stocks tumbled and Chinese indexes soared.

The S&P 500 was 0.2% lower in morning trading, coming off its sixth winning week in the last seven. The Dow Jones Industrial Average pulled back 107 points, or 0.3%, from its all-time high set on Friday. The Nasdaq composite was 0.2% lower, as of 10:15 a.m. Eastern time.

It’s a pause for Wall Street following its catapult to records on hopes the slowing U.S. economy can keep growing while the Federal Reserve cuts interest rates to offer it more juice. A big test will arrive Friday, when the U.S. government offers its latest monthly update on the job market.

An overriding worry on Wall Street is whether the economy may already be heading for a recession. Even though the Fed cut rates earlier this month and has indicated more are to come, U.S. employers have already begun slowing their hiring. Before this month, the Fed had kept interest rates at a two-decade high in hopes of slowing the economy enough to stamp out high inflation.

“Payrolls remain the biggest catalyst” for the U.S. stock market until the election, strategists and economists at Bank of America wrote in a BofA Global Research report.

At Goldman Sachs, economist David Mericle said he’s expecting Friday’s report to show hiring in September was stronger than the 146,000 growth in payrolls that economists across Wall Street are broadly forecasting.

In the past, a stronger-than-expected number could have hurt the stock market by fanning worries about upward pressure on inflation. Now, though, it would likely be welcomed as a signal that a recession shouldn’t be as big a worry.

Interest rates and the strength of the economy are usually the two main levers that set prices for stocks. In Asia, the levers were pulling in opposite directions.

Japan’s Nikkei 225 slumped 4.8% on worries that the country’s incoming prime minister will support higher interest rates and other policies that investors see as less market-friendly. Shigeru Ishiba is set to take over on Tuesday.

Ishiba has expressed support for the Bank of Japan’s move to pull interest rates away from their near-zero level, which puts upward pressure on the value of the Japanese yen. A stronger yen can hurt profits for Japanese exporters, who make sales in other currencies and then convert them back into yen.

Toyota Motor’s stock fell 7.6% in Tokyo, while Honda Motor’s dropped 7% Monday.

Stellantis, the company that owns the Jeep brand and others, tumbled 14% in Milan after cutting its forecast for upcoming profit. It cited investments to turn around its U.S. operations and increased Chinese competition.

That in turn helped to drag down automakers Ford Motor and General Motors on Wall Street. Ford fell 2.1%, and GM dropped 2.4%.

Also on Wall Street, cruise-ship operator Carnival lost 4.1% even though it reported stronger profit and revenue for the latest quarter than analysts expected. It gave a forecast for growth of an important underlying measure of profit in the current quarter that fell short of analysts' estimates.

In China, meanwhile, indexes soared 8.1% in Shanghai and 2.4% in Hong Kong following the latest announcements of stimulus for the world’s second-largest economy. It was the best day for Shanghai stocks in nearly 16 years.

China’s central bank announced moves on Sunday to ease mortgage rates for existing home loans by Oct. 31. That followed a flurry of announcements last week from China’s central bank and government intended to prop up the Chinese economy, whose growth has been flagging in part because of the weight of a struggling real-estate sector.

Markets in mainland China will be closed Tuesday through Oct. 7 for a holiday marking 75 years of communist rule.

In the bond market, the yield on the U.S. 10-year Treasury was holding steady at 3.75%, where it was late Friday. The two-year yield, which more closely tracks expectations for what the Fed will do with short-term rates, rose. It climbed to 3.59% from 3.56%.

AP Writer Zimo Zhong contributed.

FILE - The New York Stock Exchange is shown on Sept. 18, 2024, in New York. (AP Photo/Peter Morgan, File)

FILE - The New York Stock Exchange is shown on Sept. 18, 2024, in New York. (AP Photo/Peter Morgan, File)

The New York Stock Exchange, center, is shown on Friday, Sept. 27, 2024, in New York. (AP Photo/Peter Morgan)

The New York Stock Exchange, center, is shown on Friday, Sept. 27, 2024, in New York. (AP Photo/Peter Morgan)

People walk by monitors showing Japan's Nikkei 225 index at a securities firm in Tokyo, Monday, Sept. 30, 2024. (AP Photo/Hiro Komae)

People walk by monitors showing Japan's Nikkei 225 index at a securities firm in Tokyo, Monday, Sept. 30, 2024. (AP Photo/Hiro Komae)

A man walks by monitors showing Japan's Nikkei 225 index at a securities firm in Tokyo, Monday, Sept. 30, 2024. (AP Photo/Hiro Komae)

A man walks by monitors showing Japan's Nikkei 225 index at a securities firm in Tokyo, Monday, Sept. 30, 2024. (AP Photo/Hiro Komae)

A woman looks at monitors showing Japan's Nikkei 225 index at a securities firm as she waits at an traffic intersection in Tokyo, Monday, Sept. 30, 2024. (AP Photo/Hiro Komae)

A woman looks at monitors showing Japan's Nikkei 225 index at a securities firm as she waits at an traffic intersection in Tokyo, Monday, Sept. 30, 2024. (AP Photo/Hiro Komae)

A man stands by monitors showing Japan's Nikkei 225 index at a securities firm as he waits at a traffic intersection in Tokyo, Monday, Sept. 30, 2024. (AP Photo/Hiro Komae)

A man stands by monitors showing Japan's Nikkei 225 index at a securities firm as he waits at a traffic intersection in Tokyo, Monday, Sept. 30, 2024. (AP Photo/Hiro Komae)

A man who called himself a trader takes a picture of monitors showing Japan's Nikkei 225 index at a securities firm in Tokyo, Monday, Sept. 30, 2024. (AP Photo/Hiro Komae)

A man who called himself a trader takes a picture of monitors showing Japan's Nikkei 225 index at a securities firm in Tokyo, Monday, Sept. 30, 2024. (AP Photo/Hiro Komae)

A man looks at monitors showing Japan's Nikkei 225 index at a securities firm in Tokyo, Monday, Sept. 30, 2024. (AP Photo/Hiro Komae)

A man looks at monitors showing Japan's Nikkei 225 index at a securities firm in Tokyo, Monday, Sept. 30, 2024. (AP Photo/Hiro Komae)

Recommended Articles